BACTERIUM: Study for a Machine-learning-based Model to Predict Bloodstream Infections
NCT05876598 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2025-03-11
Summary
An increase of healthcare-associated infections caused by multidrug- resistant organisms (MRDO) is currently observed. One of the main causes of the emergence of a MDRO infection is an overuse of antibiotics. Therefore, saving useless antibiotic treatment is currently a priority from a public health point of view. The evaluation of the risk of having a bloodstream infection will allow both activating faster treatment decisions (when the risk is significantly high) or to save useless resources in terms of diagnostic tests and treatments, also limiting the potential for side effects (when the risk is significantly low).
Conditions
- Infection, Bloodstream
Interventions
- DRUG
-
antibiotic treatments
The outcome of the study will be to implement Prediction Models to support clinicians for the assessment of risk of having a bloodstream infection.
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Rita Murri · Fondazione Policlinico Universitario A. Gemelli, IRCCS
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-03
- Primary Completion
- 2025-06-15
- Completion
- 2025-12-30
Countries
- Italy
Study Locations
More Related Trials
-
Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Advanced NGS Sequencing Methods
NCT06322173 ·Status: RECRUITING ·Phase: NA
-
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Transmission of ESBL-producing Enterobacteriaceae
NCT03465683 ·Status: RECRUITING
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors
NCT03148769 ·Status: COMPLETED
-
Risk Factors for Carbapenem-resistant Acinetobacter Baumannii
NCT00462579 ·Status: COMPLETED
-
Clinical and Biological Impact of Gut Microbiota in Adult Patients With Bacteremia During the COVID-19 Pandemic
NCT07183722 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
NCT01764490 ·Status: COMPLETED
-
Dynamics of the Urinary Bacterial Microbiota
NCT07020676 ·Status: COMPLETED
-
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
NCT02482051 ·Status: COMPLETED
-
A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia
NCT01511224 ·Status: UNKNOWN
-
In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping
NCT07011212 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pharmacokinetics of Ertapenem in Patients Aged Over 75
NCT02505386 ·Status: COMPLETED ·Phase: PHASE4
-
The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
NCT02847065 ·Status: COMPLETED
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
Optimization Management Study of Community Urinary Tract Infections Spectrum
NCT03655548 ·Status: COMPLETED
-
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
NCT00275327 ·Status: COMPLETED
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia
NCT05394298 ·Status: UNKNOWN ·Phase: PHASE4
-
Fast Assay for Pathogen Identification and Characterization
NCT03841162 ·Status: COMPLETED
-
The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis
NCT05791357 ·Status: COMPLETED ·Phase: NA
-
Amplification and Selection of Antimicrobial Resistance in the Intestine II
NCT03140826 ·Status: COMPLETED
-
Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU
NCT05833282 ·Status: UNKNOWN
-
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
NCT03250104 ·Status: COMPLETED
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN